CC(C)[C@H]1NC(=O)[C@H]2N=C(S[C@H]2C)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CSC(=N2)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CSC1=N2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?